OBJECTIVE: To propose a research agenda that addresses technological and other knowledge gaps in developing telemonitoring solutions for patients with chronic diseases, with particular focus on detecting deterioration early enough to intervene effectively. DESIGN: A mixed methods approach incorporating literature review, key informant, and focus group interviews to gain an in-depth, multidisciplinary understanding of current approaches, and a roadmapping process to synthesise a research agenda. RESULTS: Counter to intuition, the research agenda for early detection of deterioration in patients with chronic diseases is not only primarily about advances in sensor technology but also much more about the problems of clinical specification, translation, and interfacing. The ultimate aim of telemonitoring is not fully agreed between the actors (patients, clinicians, technologists, and service providers). This leads to unresolved issues such as: (1) How are sensors used by patients as part of daily routines? (2) What are the indicators of early deterioration and how might they be used to trigger alerts? (3) How should alerts lead to appropriate levels of responses across different agencies and sectors? CONCLUSION: Attempts to use telemonitoring to improve the care of patients with chronic diseases over the last two decades have so far failed to lead to systems that are embedded in routine clinical practice. Attempts at implementation have paid insufficient attention to understanding patient and clinical needs and the complex dynamics and accountabilities that arise at the level of service models. A suggested way ahead is to co-design technology and services collaboratively with all stakeholders.
OBJECTIVE: To propose a research agenda that addresses technological and other knowledge gaps in developing telemonitoring solutions for patients with chronic diseases, with particular focus on detecting deterioration early enough to intervene effectively. DESIGN: A mixed methods approach incorporating literature review, key informant, and focus group interviews to gain an in-depth, multidisciplinary understanding of current approaches, and a roadmapping process to synthesise a research agenda. RESULTS: Counter to intuition, the research agenda for early detection of deterioration in patients with chronic diseases is not only primarily about advances in sensor technology but also much more about the problems of clinical specification, translation, and interfacing. The ultimate aim of telemonitoring is not fully agreed between the actors (patients, clinicians, technologists, and service providers). This leads to unresolved issues such as: (1) How are sensors used by patients as part of daily routines? (2) What are the indicators of early deterioration and how might they be used to trigger alerts? (3) How should alerts lead to appropriate levels of responses across different agencies and sectors? CONCLUSION: Attempts to use telemonitoring to improve the care of patients with chronic diseases over the last two decades have so far failed to lead to systems that are embedded in routine clinical practice. Attempts at implementation have paid insufficient attention to understanding patient and clinical needs and the complex dynamics and accountabilities that arise at the level of service models. A suggested way ahead is to co-design technology and services collaboratively with all stakeholders.
Authors: Kristine D Cantin-Garside; Maury A Nussbaum; Susan W White; Sunwook Kim; Chung Do Kim; Diogo M G Fortes; Rupa S Valdez Journal: J Am Med Inform Assoc Date: 2021-02-15 Impact factor: 4.497
Authors: Melinda M Davis; Michele Freeman; Jeffrey Kaye; Nancy Vuckovic; David I Buckley Journal: Telemed J E Health Date: 2014-04-14 Impact factor: 3.536
Authors: Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen Journal: Lancet Respir Med Date: 2019-09-27 Impact factor: 30.700
Authors: Alex Hardisty; Dave Roberts; Wouter Addink; Bart Aelterman; Donat Agosti; Linda Amaral-Zettler; Arturo H Ariño; Christos Arvanitidis; Thierry Backeljau; Nicolas Bailly; Lee Belbin; Walter Berendsohn; Nic Bertrand; Neil Caithness; David Campbell; Guy Cochrane; Noël Conruyt; Alastair Culham; Christian Damgaard; Neil Davies; Bruno Fady; Sarah Faulwetter; Alan Feest; Dawn Field; Eric Garnier; Guntram Geser; Jack Gilbert; David Grosser; Alex Hardisty; Bénédicte Herbinet; Donald Hobern; Andrew Jones; Yde de Jong; David King; Sandra Knapp; Hanna Koivula; Wouter Los; Chris Meyer; Robert A Morris; Norman Morrison; David Morse; Matthias Obst; Evagelos Pafilis; Larry M Page; Roderic Page; Thomas Pape; Cynthia Parr; Alan Paton; David Patterson; Elisabeth Paymal; Lyubomir Penev; Marc Pollet; Richard Pyle; Eckhard von Raab-Straube; Vincent Robert; Dave Roberts; Tim Robertson; Olivier Rovellotti; Hannu Saarenmaa; Peter Schalk; Joop Schaminee; Paul Schofield; Andy Sier; Soraya Sierra; Vince Smith; Edwin van Spronsen; Simon Thornton-Wood; Peter van Tienderen; Jan van Tol; Éamonn Ó Tuama; Peter Uetz; Lea Vaas; Régine Vignes Lebbe; Todd Vision; Duong Vu; Aaike De Wever; Richard White; Kathy Willis; Fiona Young Journal: BMC Ecol Date: 2013-04-15 Impact factor: 2.964